JAK1/2抑制剂巴瑞替尼缓解孤立性甲扁平苔藓：一例报告 - Suppr

Suppr

超能文献

Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report.

作者信息

He Juan, Weng Tengyu, Zhu Wenwei, Yang Yi, Li Chengxin

机构信息

Department of Dermatology, First Medical Center of Chinese PLA General Hospital, Beijing, China.

Department of Dermatology, The Third Medical Center of the Chinese People's Liberation Army, Beijing, China.

出版信息

J Dermatolog Treat. 2023 Dec;34(1):2274816. doi: 10.1080/09546634.2023.2274816. Epub 2023 Nov 2.

DOI:10.1080/09546634.2023.2274816

PMID:37919960

Abstract

摘要

相似文献

Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report.

J Dermatolog Treat. 2023 Dec;34(1):2274816. doi: 10.1080/09546634.2023.2274816. Epub 2023 Nov 2.

Treatment of Severe Nail Lichen Planus With Baricitinib.

JAMA Dermatol. 2022 Jan 1;158(1):107-108. doi: 10.1001/jamadermatol.2021.5082.

Recalcitrant multi-variant lichen planus successfully treated with oral baricitinib and topical ruxolitinib cream.

Dermatol Online J. 2024 Jun 15;30(3). doi: 10.5070/D330363864.

Treatment of lichen planopilaris with baricitinib: A retrospective study.

J Am Acad Dermatol. 2022 Sep;87(3):663-666. doi: 10.1016/j.jaad.2022.02.027. Epub 2022 Feb 22.

Effective treatment of refractory lichen planus pemphigoides with a Janus kinase-1/2 inhibitor.

Clin Exp Dermatol. 2022 Nov;47(11):2040-2041. doi: 10.1111/ced.15344. Epub 2022 Aug 18.

Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.

Australas J Dermatol. 2022 May;63(2):276-277. doi: 10.1111/ajd.13811. Epub 2022 Feb 25.

Baricitinib as an effective treatment for lichen planopilaris.

Dermatol Ther. 2022 Nov;35(11):e15882. doi: 10.1111/dth.15882. Epub 2022 Oct 7.

The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

Biochem Pharmacol. 2021 Oct;192:114690. doi: 10.1016/j.bcp.2021.114690. Epub 2021 Jul 16.

Ungual lichen planus. Lichen planus of the nail.

Arch Dermatol. 1979 Oct;115(10):1197-9.

Lichen planus limited to the nails in childhood: case report and literature review.

Pediatr Dermatol. 1993 Mar;10(1):36-9. doi: 10.1111/j.1525-1470.1993.tb00010.x.

引用本文的文献

Successful Treatment of Nail Lichen Planus by the Janus Kinase 1 Upadacitinib and Literature Review.

Clin Cosmet Investig Dermatol. 2025 Aug 4;18:1849-1855. doi: 10.2147/CCID.S534496. eCollection 2025.

Use of JAK Inhibitors in Lichen Planus: An Update.

Medicina (Kaunas). 2025 Jun 8;61(6):1056. doi: 10.3390/medicina61061056.

Successful Treatment of Severe Nail Lichen Planus with Janus Kinase 1 Inhibitor Abrocitinib.

Clin Cosmet Investig Dermatol. 2025 May 2;18:1095-1100. doi: 10.2147/CCID.S520633. eCollection 2025.

[Nail changes in inflammatory dermatoses: recognition and treatment].

Dermatologie (Heidelb). 2025 May;76(5):255-266. doi: 10.1007/s00105-025-05489-x. Epub 2025 Mar 11.

Therapeutic Response of Alopecia Areata-Associated Nail Changes to Baricitinib.

Case Rep Dermatol Med. 2024 Aug 31;2024:8879884. doi: 10.1155/2024/8879884. eCollection 2024.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report.

J Dermatolog Treat. 2023 Dec;34(1):2274816. doi: 10.1080/09546634.2023.2274816. Epub 2023 Nov 2.

Treatment of Severe Nail Lichen Planus With Baricitinib.

JAMA Dermatol. 2022 Jan 1;158(1):107-108. doi: 10.1001/jamadermatol.2021.5082.

Recalcitrant multi-variant lichen planus successfully treated with oral baricitinib and topical ruxolitinib cream.

Dermatol Online J. 2024 Jun 15;30(3). doi: 10.5070/D330363864.

Treatment of lichen planopilaris with baricitinib: A retrospective study.

J Am Acad Dermatol. 2022 Sep;87(3):663-666. doi: 10.1016/j.jaad.2022.02.027. Epub 2022 Feb 22.

Effective treatment of refractory lichen planus pemphigoides with a Janus kinase-1/2 inhibitor.

Clin Exp Dermatol. 2022 Nov;47(11):2040-2041. doi: 10.1111/ced.15344. Epub 2022 Aug 18.

Effective treatment of oral lichen planus with the JAK inhibitor baricitinib.

Australas J Dermatol. 2022 May;63(2):276-277. doi: 10.1111/ajd.13811. Epub 2022 Feb 25.

Baricitinib as an effective treatment for lichen planopilaris.

Dermatol Ther. 2022 Nov;35(11):e15882. doi: 10.1111/dth.15882. Epub 2022 Oct 7.

The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia.

Biochem Pharmacol. 2021 Oct;192:114690. doi: 10.1016/j.bcp.2021.114690. Epub 2021 Jul 16.

Ungual lichen planus. Lichen planus of the nail.

Arch Dermatol. 1979 Oct;115(10):1197-9.

Lichen planus limited to the nails in childhood: case report and literature review.

Pediatr Dermatol. 1993 Mar;10(1):36-9. doi: 10.1111/j.1525-1470.1993.tb00010.x.

引用本文的文献

Successful Treatment of Nail Lichen Planus by the Janus Kinase 1 Upadacitinib and Literature Review.

Clin Cosmet Investig Dermatol. 2025 Aug 4;18:1849-1855. doi: 10.2147/CCID.S534496. eCollection 2025.

Use of JAK Inhibitors in Lichen Planus: An Update.

Medicina (Kaunas). 2025 Jun 8;61(6):1056. doi: 10.3390/medicina61061056.

Successful Treatment of Severe Nail Lichen Planus with Janus Kinase 1 Inhibitor Abrocitinib.

Clin Cosmet Investig Dermatol. 2025 May 2;18:1095-1100. doi: 10.2147/CCID.S520633. eCollection 2025.

[Nail changes in inflammatory dermatoses: recognition and treatment].

Dermatologie (Heidelb). 2025 May;76(5):255-266. doi: 10.1007/s00105-025-05489-x. Epub 2025 Mar 11.

Therapeutic Response of Alopecia Areata-Associated Nail Changes to Baricitinib.

Case Rep Dermatol Med. 2024 Aug 31;2024:8879884. doi: 10.1155/2024/8879884. eCollection 2024.

Lichen Planus: What is New in Diagnosis and Treatment?

Am J Clin Dermatol. 2024 Sep;25(5):735-764. doi: 10.1007/s40257-024-00878-9. Epub 2024 Jul 9.